Date |
Event |
Presentation |
Speakers |
May 4, 2016
|
Precision Medicine Symposia On: 13th International “RNAi/MicroRNAs/Stem Cells & Genome Editing-2016 Meeting
|
Precision Medicine Symposia On: 13th International “RNAi/MicroRNAs/Stem Cells & Genome Editing-2016 Meeting
|
Dr. Xiaohong Zhang
|
March 1, 2016
|
Epigenetic Enzymes in Drug Discovery Conference
|
Regulation of Gene Transcription by DNA Methylation in Stem Cells and Neurons
|
Guoping Fan
|
January 24, 2016
|
10th PMWC 2016 Personalized Medicine World Conference
|
TRACK 4 |
|
John S Witte
|
|
|
TRACK 1 | Promoting Pharmacogenomics to the Public
|
Alan H.B. Wu
|
September 16, 2014
|
10th International BMP Conference 2014
|
BMP Signalling Pathways
|
Rik Derynck
|
|
|
BMP Crosstalks And Crossroads
|
Karen Lyons
|
May 6, 2014
|
Europe Drug Discovery Summit
|
Europe Drug Discovery Summit
|
Kevin Healy
|
February 2, 2014
|
Stem Cells and Cancer (J8)
|
Signaling Pathways in Stem Cells Registered attendees can view abstracts starting on 01/02/2014
|
Thea D. Tlsty
|
|
|
Nuclear Responses and Tumorigenesis Registered attendees can view abstracts starting on 01/02/2014
|
Marian Waterman
|
|
|
Stem Cells, Development and Cancer (Joint) Registered attendees can view abstracts starting on 01/02/2014
|
Catriona H. M. Jamieson
|
|
|
Cancer in Context: The Microenvironment and Metastasis
|
Jing Yang, Zena Werb
|
February 2, 2014
|
Developmental Pathways and Cancer: Wnt, Notch and Hedgehog (J7)
|
Signaling Pathways in Stem Cells Registered attendees can view abstracts starting on 01/02/2014
|
Thea D. Tlsty
|
|
|
Shared Signals in Stem Cells and Cancer Registered attendees can view abstracts starting on 01/02/2014
|
Thea D. Tlsty
|
|
|
Nuclear Responses and Tumorigenesis Registered attendees can view abstracts starting on 01/02/2014
|
Marian Waterman
|
|
|
Cancer in Context: The Microenvironment and Metastasis Registered attendees can view abstracts starting on 01/02/2014
|
Jing Yang
|
|
|
New Regulatory Pathways in Cancer Registered attendees can view abstracts starting on 01/02/2014
|
Zena Werb
|
November 21, 2013
|
Cell Symposia: Using Stem Cells to Model and Treat Human Disease
|
New strategies to induce immune tolerance of hESC-derived allografts
|
Yang Xu
|
|
|
Reprogramming Approaches for Cardiovascular Disease
|
Deepak Srivastava
|
October 8, 2013
|
Herrenhausen Symposium on Stem Cells and Regenerative Medicine
|
Herrenhausen Symposium on Stem Cells and Regenerative Medicine
|
Alysson Muotri
|
September 25, 2013
|
Nuclear Reprogramming and the Cancer Genome
|
Session 2 - The Cancer Genome: Genomics & Genetics
|
Gerard I Evan
|
|
|
Session 4 - Reprogramming: E pigenetics cont.
|
Yang Xu
|
|
|
Session 4 – Reprogramming: Epigenetics
|
Kathrin Plath, Bing Ren
|
September 15, 2013
|
ISSCR Regional Forum - Stem Cells in Translation
|
Cell Fate Control
|
Deepak Srivastava
|
June 10, 2013
|
2nd International Conference on Gastroenterology & Urology
|
Track 2 & 3 : Randomized, Multicenter, Controlled Evaluation of S-1 and Oxaliplatin (SOX regimen) as Neoadjuvant Chemotherapy for Advanced Gastric Cancer Patients (RESONANCE Trial, NCT01583361) --- preliminary report
|
Lin Chen
|
May 31, 2013
|
ASCO Annual Meeting 2013
|
Targeting Activated Kinases in Acute and Chronic Leukemias
|
Neil P. Shah
|
|
|
Education Session
|
Patricia A Ganz
|
April 6, 2013
|
AACR Annual Meetings
|
EPIGENETIC TARGETS FOR CANCER
|
Peter W Laird
|
|
|
BRAF Pathway Inhibitors in Melanoma: Where Do We Go from Here? Chairperson: Richard M. Marais, Paterson Institute for Cancer Research, Manchester, United Kingdom
|
Martin McMahon
|
|
|
Classification and Pathogenesis of Liver Cancers Co-Chairpersons: Josep Llovet, Mt. Sinai School of Medicine, New York, NY, and Jessica Zucman-Rossi, Inserm, Paris, France
|
Michael Karin
|
|
|
Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Claudia Petritsch
|
|
|
Target Validation by Chemical Probes/Designer Chemical Probes and Phenotypic Approach to Drug Discovery Chairperson: Michael A. Foley, Broad Institute of MIT and Harvard, Cambridge, MA
|
Kevan M Shokat
|
|
|
Pediatric Cancer: From Susceptibility to Targeted Therapies Co-Chairpersons: Katherine K. Matthay, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, and John M. Maris, Children's Hospital of Philadelphia, Philadelphia, PA
|
David H Rowitch
|
|
|
Drug Discovery in Industry, Academia, and Government: What Is the Track Record?
|
Frank McCormick
|
|
|
Epithelial Stem Cells, Morphogenesis, and Cancer Chairperson: Ian G. Macara, University of Virginia School of Medicine, Charlottesville, VA
|
Lindsay Hinck
|
|
|
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced
|
Martin McMahon
|
|
|
Nuclear Topology and Transcription Factors: Defining the Architecture of Normal and Malignant Cells Chairperson: Ari M. Melnick, Weill Cornell Medical College of Cornell University, New York, NY
|
Bing Ren
|
|
|
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY
|
Zena Werb
|
|
|
Complementing Angiogenesis Inhibitor Actions on Tumors Donald M. McDonald, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
|
Donald M. McDonald
|
|
|
Advances in High-Resolution Optical Microscopy Chairperson: Jan T. Liphardt, University of California, Berkeley, CA
|
Jan T. Liphardt
|
|
|
Measuring Metabolism in Cancer Chairperson: Ralph J. DeBerardinis, UT Southwestern Medical Center, Dallas, TX
|
Sabrina M. Ronen
|
|
|
Using Switchable Mouse Genetics to Identify Cancer Targets Gerard I. Evan, University of Cambridge, Cambridge, United Kingdom
|
Gerard I Evan
|
|
|
Transdisciplinary Cancer Research Teams: If You Build It, Will They Come? Chairperson: Julie A. Ross, University of Minnesota Masonic Cancer Center, Minneapolis, MN
|
Joseph L. Wiemels
|
|
|
Small Animal Imaging in Cancer Research Chairperson: H. Charles Manning, Vanderbilt University, Nashville, TN
|
Charles F. Caskey
|
March 21, 2013
|
The 3rd International Congress on Controversies in Cryopreservation of Stem Cells, Reproductive Cells, Tissue and Organs (CRYO)
|
Preservation of dry cells: Lessons from nature
|
John H. Crowe
|
|
|
Biobanking for the Preservation of Genetic Diversity
|
John H. Crowe
|
February 10, 2013
|
7thANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE: An Intensive Course on Translating Research into Drugs
|
New Trends in High Throughput Screening (HTS)
|
Michelle Arkin
|
|
|
Targeting Protein-Protein Interaction: A Growing Trend Towards Feasibility
|
Jim Wells
|
February 3, 2013
|
New Frontiers in Neurodegenerative Disease Research (J8)
|
Functional Genomic Analyses of Pathways Dysregulated in Frontal Temporal Dementia
|
Daniel H. Geschwind
|
January 20, 2013
|
Tumor Invasion and Metastasis
|
Session 1: The Soil
|
Zena Werb
|
October 3, 2011
|
2011 World Stem Cell Summit
|
Plenary Discussion | How Stem Cells are Transforming Medicine - ISSCR Perspectives
|
Arnold Kriegstein
|
|
|
Concurrent Sessions | Safety Issues in Stem Cell Therapies: Immunogenecity, Tumorgenicity and Genetic Stability
|
Yang Xu
|
|
|
Concurrent Sessions | New Stem Cell Discoveries - Clinical Implications
|
David Warburton
|
|
|
Stem Cells for Modeling Neurological Disorders
|
Arnold Kriegstein
|
September 11, 2011
|
Stem Cells in Development and Disease
|
Stem Cells in Development and Disease
|
Maike Sander
|
August 21, 2011
|
The TGF-β Superfamily: Signaling in Development and Disease
|
Constraints, objectives and tradeoffs in BMP-mediated patterning
|
Arthur Lander
|
|
|
Session 4 | System and Structural Biology of TGF-ß signaling
|
Arthur Lander
|
|
|
Activation of TGFß signaling
|
Rik Derynck
|
August 14, 2011
|
Gastrointestinal Tract XIV: Stem Cells, Adaptation, Inflammation and Cancer
|
Adaptive Immunity and Tumor-Associated Macrophages
|
Lisa M Coussens
|
May 26, 2011
|
Idibell Cancer Conference on Metastasis and Angiogenesis
|
Tumor malignization after antiangiogenic therapies
|
Oriol Casanovas
|
March 9, 2011
|
28th Annual Miami Breast Cancer Conferenceâ„¢
|
HER2-Positive Breast Cancer | Subtypes With Different Clinical Outcomes
|
Mark Pegram
|
|
|
Session B | "Meet the Professor" Sessions
|
Mark Pegram
|
|
|
Session B | Emerging Cytotoxic Agents for Relapsed/Refractory Metastatic Breast Cancer
|
Mark Pegram
|
|
|
Session B | What's Next in HER2-Targeted Therapy?
|
Mark Pegram
|
February 27, 2011
|
AACR-NCI Conference on Systems Biology: Confronting the Complexity of Cancer
|
Session 3 | Biomarkers as networks, not individual loci
|
T Ideker
|
|
|
Session 2 | Protein Complexes in Transcription and Signaling
|
Joe Gray
|
|
|
Educational Session | Cancer genomics in the TCGA Project
|
David Haussler
|
|
|
Educational Session | Integrative analysis of epigenomes in normal and cancer cells
|
Bing Ren
|
January 9, 2011
|
Adult Neurogenesis (A5)
|
Neural Stem Cells in Alzheimer’s Disease
|
Frank M La Ferla
|
December 8, 2010
|
33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium
|
Modeling sensitivity to therapeutic agents
|
Paul T Spellman
|
October 27, 2010
|
Colorectal Cancer: Biology to Therapy
|
Title to be announced
|
Michael Karin
|
October 20, 2010
|
6th Annual Meeting of the Oligonucleotide Therapeutics Society
|
RNaseH-Dependent Antisense Approaches for Huntington Disease
|
Don W Cleveland
|
September 12, 2010
|
Joint Metastasis Research Society-AACR Conference in Conjunction with the Tumor Microenvironment Working Group of the AACR
|
Title to be announced
|
Zena Werb
|
|
|
Session 1: TME - Stroma
|
Zena Werb
|
|
|
An integrin avb3-c-Src oncogenic unit promotes anchorage-dependence and tumor progression
|
David A. Cheresh
|
July 29, 2010
|
Neurosurgery Update 2010 in the Wine Country
|
Differential Diagnosis of Sellar Lesions
|
Manish Aghi
|
|
|
Neuro-oncology Update
|
Susan Chang
|
June 14, 2010
|
Development and Stem Cells in the Pancreas
|
HH and pancreatic tumor development in mouse models
|
Matthias Hebrok
|
May 1, 2010
|
Workshop on Animal Models for Human Stem Cell Therapy
|
Evening Debate/Discussion: Ethical issues in the use of animals for stem cell research and preclinical validation
|
Kent Lloyd
|
|
|
Repositories and resources: relevant models and where to get them | (MGI/MGD, RGD)
|
Kent Lloyd, Alice Tarental
|
|
|
Non-human primates
|
Alice Tarental
|
November 19, 2009
|
Stem Cells 2009
|
Mechanisms influencing nuclear reprogramming
|
Kathrin Plath
|
|
|
Session 4 :Self-renewal & Differentiation
|
Kathrin Plath
|
|
|
Mechanisms regulating size and maintenance of stem cell niche
|
D Leanne Jones
|
|
|
Session 7 :Cancer
|
D Leanne Jones
|
October 1, 2009
|
6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO)
|
Introduction and ISGIO Presidential Inauguration
|
J F Marshall
|
|
|
Session 3: Advanced Colorectal Cancer
|
J F Marshall
|
March 25, 2009
|
The Stem Cell Meeting '09 Agenda
|
Keynote Presentation: Can Stem Cells Transform Healthcare?
|
Alan O Trounson
|
January 25, 2009
|
"Emerging Themes in Tumor Suppressors: Function and Clinical Implications in the Post-Genomic Era (B1)
|
Tissue Context and Tumor Suppressor Function
|
Colleen A Fordyce
|
January 5, 2009
|
High Content Analysis
|
Live-Cell Imaging and Analysis of Cell Cycle Timing, Mitosis and Cell Death
|
Samantha G Zeitlin
|
December 7, 2008
|
AMERICAN SOCIETY FOR MATRIX BIOLOGY 2008 Meeting
|
SIG 1: Versican in Regulating Tumor Macrophages
|
Michael Karin
|
|
|
Concurrent B: Hypertriglyceridemia caused by mutation of the basement membrane proteoglycan Type XVIII collagen
|
Jeffrey D. Esko
|
|
|
Concurrent E: Control challenges in tissue growth and patterning
|
Arthur Lander
|
|
|
Concurrent J: Integrin-mediated activation of TGFβ
|
Dean Sheppard
|
|
|
Mutant COL4A1 triggers oxidative stress in a genetic model of AMD
|
Yi-Chinn Weng,
|
|
|
Matrix Cross Linking, Mechanotransduction and Tumor Progression
|
Valerie M Weaver
|
|
|
Concurrent M: Cell polarity regulated by a FAKp120RasGAP- p190RhoGAP complex
|
Alok Tomar,
|
November 22, 2008
|
Collaborative Ependymoma Research Network (CERN)
|
FoxM1 Overexpression And DNA Amplification In Pediatric Astrocytomas
|
Graeme Hodgson
|
September 29, 2008
|
Stem Cells, Cancer and Aging (S3)
|
Models of Aging
|
Alea A Mills
|
|
|
Regulating Tumor Suppression
|
Gerard I Evan
|
|
|
Signaling Pathways in Cancer and Development
|
Michael Karin
|
June 11, 2008
|
6th ISSCR Annual Meeting
|
PROSTATE STEM CELLS AND CANCER PROGRESSION
|
Owen Witte
|
|
|
Panel
|
Kathrin Plath
|
|
|
Plenary Session VI: Embryonic Stem Cells
|
Alan O Trounson
|
May 30, 2008
|
ASCO Annual'08 Meeting
|
cancer genetics-- New Models for Assessment of Hereditary Cancer Risk
|
Steve M. Lipkin
|
|
|
cancer prevention/epidemiology-- New Models for Assessment of Hereditary Cancer Risk
|
Steve M. Lipkin
|
|
|
cancer prevention/epidemiology-- Targeting Infection and Inflammation for Cancer Prevention (M22)
|
Michael Karin
|
|
|
geriatric oncology-- Opportunities for Clinicians and Researchers Interested in Geriatric Oncology (M16)
|
Arash Naeim
|
|
|
leukemia, myelodysplasia, and transplantation-- Advances in Chronic Lymphocytic Leukemia from Biology to Bedside
|
Thomas J. Kipps
|
|
|
leukemia, myelodysplasia, and transplantation-- ASCO/American Society of Hematology Symposium. Reducing and Enhancing Hematopoietic Cell Growth: New Developments in the Pathogenesis and Treatment of Acute Leukemia and the Therapeutic Uses of Hematopoietic Growth Factors
|
Kenneth Kaushansky
|
|
|
lymphoma and plasma cell disorders-- ASCO/American Society of Hematology Symposium. Reducing and Enhancing Hematopoietic Cell Growth: New Developments in the Pathogenesis and Treatment of Acute Leukemia and the Therapeutic Uses of Hematopoietic Growth Factors
|
Kenneth Kaushansky
|
|
|
patient and survivor care-- New Models for Survivorship Care Programs (M15)
|
Patricia A Ganz
|
|
|
professional development-- Opportunities for Clinicians and Researchers Interested in Geriatric Oncology (M16)
|
Arash Naeim
|
|
|
special sessions-- American Cancer Society Award and Lecture
|
Patricia A Ganz
|
|
|
special sessions-- ASCO/American Society of Hematology Symposium. Reducing and Enhancing Hematopoietic Cell Growth: New Developments in the Pathogenesis and Treatment of Acute Leukemia and the Therapeutic Uses of Hematopoietic Growth Factors
|
Kenneth Kaushansky
|
|
|
meet the professor sessions-- Targeting Infection and Inflammation for Cancer Prevention (M22)
|
Michael Karin
|
|
|
meet the professor sessions-- New Models for Survivorship Care Programs (M15)
|
Patricia A Ganz
|
|
|
meet the professor sessions-- Opportunities for Clinicians and Researchers Interested in Geriatric Oncology (M16)
|
Arash Naeim
|
May 7, 2008
|
2nd annual Lab-on-a-Chip World Congress
|
Nanomechanical Analysis of Cells from Cancer Patients
|
Jianyu Rao
|
May 4, 2008
|
Impact China IV: Pharmaceutical R&D Global Summit
|
Elective: Track B: Reforms & Regulations: Commercializing University Intellectual Property
|
Sean Caffey
|
April 6, 2008
|
Islet and Beta Cell Development and Transplantation
|
Stem Cells and Pancreatic Islets
|
Maike Sander
|
|
|
Mediators of Beta Cell Stress
|
Feroz R. Papa
|
|
|
Pancreatic Development – Intercellular Signaling
|
Maike Sander, Matthias Hebrok
|
|
|
Mechanisms of Beta-Cell Failure In Disease and Possible Drug Targets
|
Peter C. Butler
|
March 30, 2008
|
Inflammation, Microenvironment and Cancer
|
Microenvironment
|
R S Johnson
|
|
|
Animal Models
|
Michael Karin, Lisa M Coussens
|
|
|
Therapeutics
|
David A. Cheresh
|
March 25, 2008
|
THE STEM CELLS CONGRESS
|
Challenges for Discoveries and Translation for Stem Cell Research
|
Alan O Trounson
|
|
|
Mesenchyamal Stem Cells for Vascular Regeneration
|
Song Li
|
|
|
Transplantation of CNS Progenitor Cells to the Mammalian Retina
|
Henry Klassen
|
March 25, 2008
|
TRANSLATIONAL MEDICINE
|
Impact of Translational Methods on Drug Development
|
Richard Sachse
|
March 25, 2008
|
CYTOKINE-BASED THERAPEUTICS
|
Chemokines and Chemokine Receptors:
|
Israel F Charo
|
March 24, 2008
|
Signaling Pathways in Cancer and Development
|
Proliferation, Aging and Cancer
|
D Leanne Jones
|
|
|
Organogenesis and Cancer
|
Catriona H. M. Jamieson
|
|
|
Stem Cell Renewal Mechanisms
|
Kathrin Plath
|
March 9, 2008
|
DNA DAMAGE, MUTATION & CANCER
|
KEYNOTE ADDRESSES
|
John B Hays
|
February 24, 2008
|
Tumor Suppressors and Stem Cell Biology
|
Tumor Suppressors and Regeneration
|
D Leanne Jones
|
February 17, 2008
|
Wnt/beta-Catenin Signaling in Development and Disease
|
Wnt Regulation of Gene Expression
|
Marian Waterman
|
February 12, 2008
|
AACR - The Role of Cancer Stem Cells in the Initiation and Propagation of Tumorigenesis
|
Stem Cells and Prostate Cancer
|
Owen Witte
|
|
|
Effects of Hyperactive Ras on Stem Cell Fates
|
Kevin M Shannon
|
|
|
SESSION 7: TUMOR STEM CELL NICHE
|
Thea D. Tlsty
|
|
|
Mechanisms of Genetic and Epigenetic (tumor/stem) Cell Plasticity
|
Thea D. Tlsty
|
|
|
Targeting Cancer Stem Cells
|
Catriona H. M. Jamieson
|
February 11, 2008
|
Stem Cells World Congress
|
Genome-wide Profiling of DNA Methylation Patterns in Pluripotent Embryonic Stem Cells
|
Guoping Fan
|
January 22, 2008
|
Ubiquitin and Cancer: From Molecular Targets and Mechanisms to the Clinic
|
Mechanisms of Ubiquitin Chain Assembly and Substrate Degradation
|
Raymond J Deshaies
|
|
|
SESSION 3: UBIQUITIN, TRANSCRIPTION, AND EPIGENETICS I
|
Raymond J Deshaies
|
|
|
Control of DNA Methylation and Heterochromatic Silencing in Arabidopsis by Histone H2B Deubiquitination
|
Jian-Kang Zhu
|
January 18, 2008
|
Translational Research Program Stem Cell Symposium
|
Breast
|
Frank Pajonk
|
|
|
Normal Stem Cells and Normal Tissue Injury
|
John R Fike
|
January 15, 2008
|
Molecular, Cellular, Physiological, and Pathogenic Responses to Hypoxia
|
Adaptive Responses to Hypoxia
|
R S Johnson
|
|
|
Endothelial Guidance and Signaling
|
Luisa Iruela-Arispe
|
|
|
Development and Differentiation
|
R S Johnson
|
|
|
Angiogenesis in Disease & Tissue Maintenance
|
Donald M. McDonald
|
|
|
Extracellular Matrix and Angiogenesis
|
R. Andrea DeYoung, David A Cheresh
|
|
|
Pathological Angiogenesis
|
Gabriele A.I. Bergers
|
|
|
Workshop 3: Vascular Cell Signaling
|
Donald M. McDonald
|
|
|
Novel Therapeutic Targets in Angiogenesis
|
Gabriele A.I. Bergers, Sara Weis
|
January 13, 2008
|
Pathological and Physiological Regulation of Cardiac Hypertrophy
|
MicroRNAs in Cardiac Development and Disease
|
Deepak Srivastava
|
|
|
Hibernating and Feeding: What We Can Learn from Nature about Maintenance of Cardiac and Skeletal Muscle Mass
|
Vincent Caiozzo
|
December 13, 2007
|
Stem Cells 2007
|
TBC
|
Simon Tavare
|
December 5, 2007
|
Sixth Annual International Conference on Frontiers in Cancer Prevention Research
|
PLENARY SESSION II - IMMUNE SYSTEM AS A TARGET FOR PREVENTION
|
Lisa M Coussens
|
December 1, 2007
|
47TH American Socieity of Cell Biology
|
Membrane Dynamics
|
Kit Pogliano
|
|
|
Remodeling Cellular Membranes during Bacillus subtilis Sporulation. K. Pogliano; University of California, San Diego,
|
Kit Pogliano
|
|
|
Design Principles for Connecting the Genome to the World
|
D. Drubin
|
|
|
Minisymposium 1A:Cell Biology Working Group: Challenges in Cell Biology—The Nature of Cytoplasm
|
R. Dyche Mullins, Rob Phillips, Wallace F Marshall
|
|
|
Minisymposium 1B:Cell Biology Working Group: Challenges in Cell Biology—The Cell Biology of Alzheimer’s Disease
|
R. Dyche Mullins, Lennart Mucke, Jonathan Weissman
|
|
|
Interphase and Mitotic CDKs Follow Kinetically Distinct Paths to Activation in Human Cells.
|
K. A. Merrick, K M Shokat
|
|
|
Opening Plenary
|
Elma Gonzalez
|
|
|
CLASPs Clutching Microtubule Networks (Room 209 B/C)
|
Praveen Kumar
|
|
|
Building the Cell (Room 140B)
|
Wallace F Marshall
|
|
|
Systems Biology of Receptor Tyrosine Kinase Networks (Room 206)
|
Anand R. Asthagiri
|
|
|
The NCI Alliance for Nanotechnology in Cancer: Creating Next
|
Douglas Hanahan
|
|
|
The Function and Regulation of Dendritic Golgi Outposts
|
B Ye, Y Zhang, L Y Jan, Y Jan
|
|
|
Structure Elements Necessary for Oligomerization, Traffi cking, and Cell Sorting Function of Paraxial Protocadherin
|
X Chen
|
|
|
E. B. Wilson Medal Presentation and Address
|
Zena Werb
|
|
|
Symposium V Ballrooms A/B/C
|
Peter Bryant
|
|
|
Transformation: A Force to Resist.
|
V M Weaver
|
|
|
Single Molecule Studies:Steve Kowalczykowski, University of California, Davis, Rob Phillips (Chair), California Institute of Technology,
|
Rob Phillips
|
|
|
Visualization of DNA Motor Proteins and Nucleoprotein Filaments at the Single-Molecule Level.
|
Stephen C Kowalczykowski
|
|
|
Cell Biology in Ten YearsCell Biology in Ten YearsCell Biology in Ten YearsCell Biology in Ten Yearsv
|
David Haussler
|
|
|
Decoding Genomes with Comparative Genomics.
|
David Haussler
|
|
|
Workshop:Useful Databases for Cell Biologists
|
David Haussler, Robert Kuhn
|
|
|
Characterization of a Novel Vertebrate Actin Nucleation Factor.
|
J. Zuchero, R. Dyche Mullins
|
|
|
A Requirement of Xenopus Nudel, a Dynein Regulator, for Assembly of Spindle Precursors Enriched for Lamin B Matrix
|
R Chen
|
|
|
Cell Biology of the Synapse:
|
Graeme W Davis
|
|
|
Synapse Stability Versus Degeneration: The Presynaptic Spectrin/Ankyrin Skeleton and Downstream Neuroprotective
|
Graeme W Davis, C M Massaro, J Pielage
|
|
|
The Third Dimension Drives N-CoR2-dependent Death Resistance.
|
Valerie M Weaver, K K Tsai, J N Lakins, M E Werner
|
|
|
High-Tech Cell Biology
|
Grant J Jensen
|
|
|
3-D Ultrastructure of Ostreococcus tauri: Electron Cryotomography of an Entire Eukaryotic Cell.
|
L Gan, Gregory P Henderson, Grant J Jensen
|
|
|
Mitochondrial Morphology: Quantifying Topological Network Properties in 3 Dimensions.
|
S Rafelski, Peter M Carlton, J W Sedat, Wallace F Marshall
|
|
|
Label-Free, Single-Molecule Detection of Cytokines in Serum Using Optical Microcavities.
|
Andrea M Armani, S E Fraser, Kerry J. Vahala
|
|
|
Heterochromatin Formation in Fission Yeast.
|
F. Li
|
|
|
Stem Cell Niches
|
D Leanne Jones
|
|
|
Somatic Stem Cells Maintain the Niche in the Drosophila Testis.
|
D Leanne Jones
|
|
|
Microtubule and Src Dynamics in Neuronal Growth Cones during Adhesion-mediated Guidance
|
B Wu
|
|
|
Mallory Body Formation in the Livers of Drug-primed Mice Is Regulated by an Epigenetic Mechanism
|
J. V. Oliva, F Amidi, Samuel W French, Barbara A French
|
|
|
High Rates of Aneuploidy Cause Cell Death and Tumor Suppression
|
A. D Silk, Don W Cleveland
|
|
|
Binding of the HBV X Protein to hBubR1 Disturbs the Mitotic Checkpoint and Increases Chromosome Instability
|
G Chan
|
|
|
In Vitro and In Silico Reconstitution of DNA Segregation: A 3 Component, Kinetically Self-contained Plasmid DNA Segregating Spindle
|
Bruce Alberts, R. Dyche Mullins
|
|
|
Mammary Epithelial Morphogenesis Results from the Coordinate and Opposing Motility of Luminal and Myoepithelial cells
|
J Ewald, B S Chan, M Duong, Zena Werb
|
|
|
Systems Approaches to Understanding Peroxisome Biogenesis
|
Y Wang
|
|
|
A Conserved Network of Human MAPK Interactions
|
M Gersten, S Bandyopadhyay, T Ideker
|
|
|
Transcriptome and Interaction Analyses of the Giardia lamblia Basal Body Proteome.
|
T Lauwaet, D Reiner, B Davids, F D Gillin
|
|
|
An E-MAP of Kinase and Phosphatase Signaling in Saccharomyces cerevisiae
|
D Fiedler, S R Collins, Y Nijati, K M Shokat, Nevan J. Krogan
|
|
|
Capping Protein Controls the Rate of Actin Filament Nucleation by the Arp2/3 Complex
|
R. Dyche Mullins, Orkun Akin
|
|
|
Challenges and Opportunities for NIH Peer Review
|
Keith Yamamoto
|
November 7, 2007
|
Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13)
|
Session 2: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part I) (13:30-17:30)
|
Dr. Xiaohong Zhang
|
|
|
session 2: Deacetylation of cortactin by SIRT1 promotes ovarian and breast cancer cell migration (16:45-17:05)
|
Dr. Xiaohong Zhang
|
|
|
Session 4: (Part One) Anti-Infectious Drug Discovery & Development (I) (Part Two) RNAi & Gene: Applications in Drug Discovery and Therapeutics (13:30-17:05)
|
Dr. Victoria V. Lunyak
|
|
|
Session 4: Diving into the DNA Dumpster: SINE B2 Repeat Transcription is Responsible for the Organization of the Growth Hormone Gene Locus in Mouse Development (16:20-16:40)
|
Dr. Victoria V. Lunyak
|
|
|
Session 5: Liver Disease Drug Discovery & Development and Innovative Therapeutics (09:00-12:10)
|
Dr. Bangyan Stiles
|
|
|
Session 5: Discovery of New Therapeutic Targets Using Liver Pten Deletion Animal Model (10:40-11:00)
|
Dr. Bangyan Stiles
|
|
|
Session 7: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part II) (09:00-12:00)
|
Jianyu Rao
|
|
|
Session 7: Cancer Chemoprevention and Biomarkers (10:40-11:00)
|
Jianyu Rao
|
|
|
Session 14: Cardiovascular and Heart Disease Drug Discovery & Development to Innovative Therapeutics (13:30-17:30)
|
Ernst R. Schwarz
|
|
|
Session 14: A Novel Aqueous Alprostadil Formulation with Excellent Superficial Skin Penetration but without Hypersensitivity or Skin Irritation for the Treatment of Female Sexual Arousal Disorder (14:45-15:10)
|
Ernst R. Schwarz
|
November 4, 2007
|
AACR Centennial Conference: Translational Cancer Medicine
|
Plenary Session 1: Frontier Technologies
|
Joe Gray
|
|
|
Concurrent Session 1: Clinical Pharmacogenetics: Assessing Global Diversity
|
Pui Yan KWOK
|
August 11, 2007
|
Gastrointestinal Tract XII: The Molecular and Integrative Basis for GI Development, Homeostasis and Disease
|
Using zebrafish to dissect the pathways involved in luminal gut development
|
Didier Stainier
|
|
|
Inflammatory mechanisms of gastrointestinal cancer development
|
Michael Karin
|
|
|
Guts, microbes and the evolution of herbivory in reptiles
|
Robert E Espinoza
|
|
|
The role of alpha defensins in the small intestine
|
Andre J Ouellette
|
March 12, 2007
|
THE STEM CELL MEETING – Burrill and Compay
|
SPECIAL EVENTS Conversations with Experts Roundtable Luncheon-- Fighting for Government Funding
|
Don Reed
|
|
|
SPECIAL EVENTS Conversations with Experts Roundtable Luncheon-- Topic TBD,
|
Wayne W. Grody
|